Maternal BCG scar is associated with increased infant proinflammatory immune responses.
about
Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.What Have We Learnt about BCG Vaccination in the Last 20 Years?Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial.Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial.Heterologous effects of infant BCG vaccination: potential mechanisms of immunity
P2860
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@en
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@nl
type
label
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@en
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@nl
prefLabel
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@en
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@nl
P2093
P2860
P50
P1433
P1476
Maternal BCG scar is associated with increased infant proinflammatory immune responses.
@en
P2093
Abdelali Filali-Mouhim
Emily L Webb
Patrice Akusa Mawa
Sarah Prentice
Stephen Nash
P2860
P304
P356
10.1016/J.VACCINE.2016.11.079
P407
P577
2016-11-30T00:00:00Z